UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

TELEPRO: Patient‐Reported Carcinoid Syndrome Symptom Improvement Following Initiation of Telotristat Ethyl in the Real World

The oncologist (Dayton, Ohio), 2019-11, Vol.24 (11), p.1446-1452

2019

Volltextzugriff (PDF)

The role of microtubule actin cross-linking factor 1 (MACF1) in the Wnt signaling pathway

Genes & development, 2006-07, Vol.20 (14), p.1933-1945

2006

Volltextzugriff (PDF)

Development of inhibitors of the IGF-IR/PI3K/Akt/mTOR pathway

Reviews on recent clinical trials, 2010-09, Vol.5 (3), p.189-208

2010

Volltextzugriff (PDF)

CTIM-17. ADDITIONAL RESULTS FROM A PHASE 1B STUDY OF IGV-001 IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA

Neuro-oncology (Charlottesville, Va.), 2023-11, Vol.25 (Supplement_5), p.v65-v65

2023

Volltextzugriff (PDF)

In Reply: Telotristat Ethyl for Patients With Carcinoid Syndrome Associated With Chest Pain and Hypertension

Pancreas, 2018-10, Vol.47 (9), p.e57-e57

2018

Volltextzugriff (PDF)

Is a novel I214M substitution in the NEFL gene a cause of Charcot-Marie-Tooth disease? Functional analysis using cell culture models

Journal of the peripheral nervous system, 2006-09, Vol.11 (3), p.225-231

2006

Volltextzugriff (PDF)

Correction to: Targeted immunotherapy for glioblastoma involving whole tumor-derived autologous cells in the upfront setting after craniotomy

Journal of neuro-oncology, 2024-04, Vol.167 (2), p.369-369

2024

Volltextzugriff (PDF)

Targeted immunotherapy for glioblastoma involving whole tumor-derived autologous cells in the upfront setting after craniotomy

Journal of neuro-oncology, 2023-12, Vol.165 (3), p.389-398

2023

Volltextzugriff (PDF)

Burden of Carcinoid Heart Disease in Patients With Carcinoid Syndrome Initiating Somatostatin Analogues

Clinical therapeutics, 2019-09, Vol.41 (9), p.1716-1723.e2

2019

Volltextzugriff (PDF)

Burden of carcinoid heart disease in patients initiating treatment for carcinoid syndrome

Journal of clinical oncology, 2019-02, Vol.37 (4_suppl), p.262-262

2019

Volltextzugriff (PDF)

Margetuximab Versus Trastuzumab in Patients With Previously Treated HER2-Positive Advanced Breast Cancer (SOPHIA): Final Overall Survival Results From a Randomized Phase 3 Trial

Journal of clinical oncology, 2023-01, Vol.41 (2), p.198-205

2023

Volltextzugriff (PDF)

Phenotypic analysis of neurofilament light gene mutations linked to Charcot-Marie-Tooth disease in cell culture models

Human molecular genetics, 2004-10, Vol.13 (19), p.2207-2220

2004

Volltextzugriff (PDF)

Direct costs of carcinoid syndrome diarrhea among adults in the United States

World journal of gastroenterology : WJG, 2019-12, Vol.25 (47), p.6857-6865

2019

Volltextzugriff (PDF)

TIPS-18 TRIAL IN PROGRESS: A RANDOMIZED, MULTICENTER, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE 2B STUDY TO ASSESS THE SAFETY AND EFFICACY OF IGV-001, AN AUTOLOGOUS CELL IMMUNOTHERAPY WITH ANTISENSE OLIGONUCLEOTIDE (IMV-001) TARGETING IGF-1R, IN NEWLY DIAGNOSED PATIENTS WITH GLIOBLASTOMA

Neuro-oncology advances, 2023-08, Vol.5 (Supplement_3), p.iii38-iii38

2023

Volltextzugriff (PDF)

RTID-08. A RANDOMIZED, MULTICENTER, DOUBLE-BLIND, PHASE 2B STUDY OF IGV-001, AN AUTOLOGOUS CELL IMMUNOTHERAPY WITH ANTISENSE OLIGO IMV-001 TARGETING IGF-1R, VS PLACEBO, IN NEWLY DIAGNOSED GLIOBLASTOMA PATIENTS

Neuro-oncology (Charlottesville, Va.), 2023-11, Vol.25 (Supplement_5), p.v260-v260

2023

Volltextzugriff (PDF)

Work productivity burden and indirect costs associated with carcinoid syndrome diarrhea

Expert review of pharmacoeconomics & outcomes research, 2020-09, Vol.20 (5), p.507-511

2020

Volltextzugriff (PDF)

Autologous cell immunotherapy (IGV-001) with IGF-1R antisense oligonucleotide in newly diagnosed glioblastoma patients

Future oncology (London, England), 2024-03, Vol.20 (10), p.579-591

2024

Volltextzugriff (PDF)

The G336S Variant in the Human Neurofilament-M Gene Does Not Affect Its Assembly or Distribution: Importance of the Functional Analysis of Neurofilament Variants

Journal of neuropathology and experimental neurology, 2004-07, Vol.63 (7), p.759-774

2004

Volltextzugriff (PDF)

Mutations in the neurofilament light gene linked to Charcot‐Marie‐Tooth disease cause defects in transport

Journal of neurochemistry, 2005-05, Vol.93 (4), p.861-874

2005

Volltextzugriff (PDF)

RESEARCH REPORT: Is a novel I214M substitution in the NEFL gene a cause of Charcot-Marie-Tooth disease? Functional analysis using cell culture models

Journal of the peripheral nervous system, 2006-09, Vol.11 (3), p.225-231

2006

Volltextzugriff (PDF)

Genotype-phenotype characterization of neurofilament light gene mutations linked to Charcot -Marie -Tooth disease

Perez-Olle, Raul

2003

Volltextzugriff (PDF)

An AC-repeat adjacent to mouse Cdkn2B allows the detection of specific allelic losses in the p15INK4b and p16INK4a tumor suppressor genes

Mammalian genome, 1998-03, Vol.9 (3), p.183-185

1998

Volltextzugriff (PDF)

An AC-repeat adjacent to mouse Cdkn2B allows the detection of specific allelic losses in the p15 INK4b and p16 INK4a tumor suppressor genes

Mammalian genome, 1998-03, Vol.9 (3), p.183-185

1998

Volltextzugriff (PDF)

1 – 23 von 23

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(21)
Mit Volltextzugriff
(18)

Publikationsform

Artikel
(22)
Dissertationen
(1)

Sprache

Englisch
(23)
Japanisch
(4)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

TELEPRO: Patient‐Reported Carcinoid Syndrome Symptom Improvement Following Initiation of Telotristat Ethyl in the Real World

The role of microtubule actin cross-linking factor 1 (MACF1) in the Wnt signaling pathway

Development of inhibitors of the IGF-IR/PI3K/Akt/mTOR pathway

CTIM-17. ADDITIONAL RESULTS FROM A PHASE 1B STUDY OF IGV-001 IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA

In Reply: Telotristat Ethyl for Patients With Carcinoid Syndrome Associated With Chest Pain and Hypertension

Is a novel I214M substitution in the NEFL gene a cause of Charcot-Marie-Tooth disease? Functional analysis using cell culture models

Correction to: Targeted immunotherapy for glioblastoma involving whole tumor-derived autologous cells in the upfront setting after craniotomy

Targeted immunotherapy for glioblastoma involving whole tumor-derived autologous cells in the upfront setting after craniotomy

Burden of Carcinoid Heart Disease in Patients With Carcinoid Syndrome Initiating Somatostatin Analogues

Burden of carcinoid heart disease in patients initiating treatment for carcinoid syndrome

Margetuximab Versus Trastuzumab in Patients With Previously Treated HER2-Positive Advanced Breast Cancer (SOPHIA): Final Overall Survival Results From a Randomized Phase 3 Trial

Phenotypic analysis of neurofilament light gene mutations linked to Charcot-Marie-Tooth disease in cell culture models

Direct costs of carcinoid syndrome diarrhea among adults in the United States

TIPS-18 TRIAL IN PROGRESS: A RANDOMIZED, MULTICENTER, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE 2B STUDY TO ASSESS THE SAFETY AND EFFICACY OF IGV-001, AN AUTOLOGOUS CELL IMMUNOTHERAPY WITH ANTISENSE OLIGONUCLEOTIDE (IMV-001) TARGETING IGF-1R, IN NEWLY DIAGNOSED PATIENTS WITH GLIOBLASTOMA

RTID-08. A RANDOMIZED, MULTICENTER, DOUBLE-BLIND, PHASE 2B STUDY OF IGV-001, AN AUTOLOGOUS CELL IMMUNOTHERAPY WITH ANTISENSE OLIGO IMV-001 TARGETING IGF-1R, VS PLACEBO, IN NEWLY DIAGNOSED GLIOBLASTOMA PATIENTS

Work productivity burden and indirect costs associated with carcinoid syndrome diarrhea

Autologous cell immunotherapy (IGV-001) with IGF-1R antisense oligonucleotide in newly diagnosed glioblastoma patients

The G336S Variant in the Human Neurofilament-M Gene Does Not Affect Its Assembly or Distribution: Importance of the Functional Analysis of Neurofilament Variants

Mutations in the neurofilament light gene linked to Charcot‐Marie‐Tooth disease cause defects in transport

RESEARCH REPORT: Is a novel I214M substitution in the NEFL gene a cause of Charcot-Marie-Tooth disease? Functional analysis using cell culture models

Genotype-phenotype characterization of neurofilament light gene mutations linked to Charcot -Marie -Tooth disease

An AC-repeat adjacent to mouse Cdkn2B allows the detection of specific allelic losses in the p15INK4b and p16INK4a tumor suppressor genes

An AC-repeat adjacent to mouse Cdkn2B allows the detection of specific allelic losses in the p15 INK4b and p16 INK4a tumor suppressor genes

Suchergebnisse filtern